Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Common Equity (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Common Equity data on record, last reported at $16.6 billion in Q4 2025.

  • For Q4 2025, Common Equity rose 6.74% year-over-year to $16.6 billion; the TTM value through Dec 2025 reached $16.6 billion, up 6.74%, while the annual FY2025 figure was $16.1 billion, 2.28% up from the prior year.
  • Common Equity reached $16.6 billion in Q4 2025 per FMS's latest filing, up from $15.6 billion in the prior quarter.
  • Across five years, Common Equity topped out at $16.6 billion in Q4 2025 and bottomed at $15.6 billion in Q4 2024.
  • Average Common Equity over 4 years is $16.0 billion, with a median of $15.9 billion recorded in 2021.
  • Peak YoY movement for Common Equity: rose 8.77% in 2021, then decreased 1.44% in 2022.
  • A 4-year view of Common Equity shows it stood at $16.0 billion in 2021, then decreased by 1.44% to $15.8 billion in 2022, then dropped by 1.18% to $15.6 billion in 2024, then rose by 6.74% to $16.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $16.6 billion in Q4 2025, $15.6 billion in Q4 2024, and $15.8 billion in Q4 2022.